Download Citation
Article Source:
Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation
Arnold SA,
Rivera LB,
Carbon JG,
Toombs JE,
Chang CL,
et al.
(2012)
Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation.
PLOS ONE 7(2): e31384.
https://doi.org/10.1371/journal.pone.0031384